4D Molecular Therapeutics, Inc. (FDMT) Total assets 2019–2025
4D Molecular Therapeutics, Inc. (FDMT) total assets at each fiscal year-end, per SEC filings.
$566.7MFY2025 · since FY2019: $58.2M → $566.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $566.7M | +1.1% |
| FY2024 | $560.4M | +64.9% |
| FY2023 | $339.9M | +29.8% |
| FY2022 | $261.8M | -25.9% |
| FY2021 | $353.5M | +22.6% |
| FY2020 | $288.3M | +395.1% |
| FY2019 | $58.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FDMT financial trends
FDMT RevenueFDMT Net incomeFDMT Net marginFDMT Gross profitFDMT Gross marginFDMT Operating incomeFDMT Operating marginFDMT Operating cash flowFDMT Free cash flowFDMT Capital expendituresFDMT Return on equityFDMT Stock buybacksFDMT Dividends paidFDMT Total liabilitiesFDMT Shareholders’ equityFDMT overview →